Author： Khasnavis Saurabh Roy Avik Ghosh Supurna Watson Richard Pahan Kalipada
Publisher： Springer Publishing Company
ISSN： 1557-1890
Source： Journal of Neuroimmune Pharmacology, Vol.9, Iss.2, 2014-03, pp. : 218-232
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
Dopaminergic substitution in Parkinson’s disease
Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 10, 2002-10 ,pp. :
Access to resources
Recommend
CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 6, Iss. 4, 2007-08 ,pp. :
Non-dopaminergic drug treatment of Parkinson’s disease
By Müller T.
Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 4, 2001-04 ,pp. :
Existing dopaminergic therapies for Parkinson’s disease
By Dutta PhD Aloke K Le MD PhD Weidong
Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 12, 2006-12 ,pp. :